We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

251 hedge funds and large institutions have $1.91B invested in Ironwood Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 87 increasing their positions, 94 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $24.5M | Put options by funds: $11.5M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

22% more capital invested

Capital invested by funds: $1.56B → $1.91B (+$349M)

4.72% more ownership

Funds ownership: 102.33% → 107.05% (+4.7%)

1% more funds holding

Funds holding: 248 → 251 (+3)

7% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 94

Holders
251
Holders Change
+3
Holders Change %
+1.21%
% of All Funds
3.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
32
Increased
87
Reduced
94
Closed
26
Calls
$24.5M
Puts
$11.5M
Net Calls
+$13M
Net Calls Change
+$12.4M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$23.7M
2
AC
Armistice Capital
New York
+$22.2M
3
Man Group
Man Group
United Kingdom
+$14.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M
5
CS
Credit Suisse
Switzerland
+$11M

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$24.1M
2
B
Braidwell
Connecticut
-$13M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.4M
4
Two Sigma Investments
Two Sigma Investments
New York
-$8M
5
American Century Companies
American Century Companies
Missouri
-$4.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
B
251
Braidwell
Connecticut
– -$13M -1,348,099 Closed
SG Americas Securities
252
SG Americas Securities
New York
– -$1.82M -188,807 Closed
Walleye Capital
253
Walleye Capital
New York
– -$1.61M -166,968 Closed
IMRF
254
Illinois Municipal Retirement Fund
Illinois
– -$743K -77,141 Closed
Verition Fund Management
255
Verition Fund Management
Connecticut
– -$698K -72,462 Closed
Jennison Associates
256
Jennison Associates
New York
– -$686K -71,240 Closed
AIA
257
Affinity Investment Advisors
California
– -$489K -50,733 Closed
EP
258
Edgestream Partners
New Jersey
– -$467K -48,528 Closed
CIC
259
Cornercap Investment Counsel
Georgia
– -$462K -47,941 Closed
Allianz Asset Management
260
Allianz Asset Management
Germany
– -$395K -41,000 Closed
CA
261
Clearstead Advisors
Ohio
– -$385K -40,000 Closed
FHB
262
First Hawaiian Bank
Hawaii
– -$334K -34,730 Closed
SGI
263
Summit Global Investments
Utah
– -$320K -33,225 Closed
Schroder Investment Management Group
264
Schroder Investment Management Group
United Kingdom
– -$291K -30,256 Closed
First Manhattan
265
First Manhattan
New York
– -$277K -28,758 Closed
Sumitomo Mitsui Trust Group
266
Sumitomo Mitsui Trust Group
Japan
– -$264K -27,373 Closed
PFS
267
Prospera Financial Services
Texas
– -$251K -26,067 Closed
DFCM
268
Dark Forest Capital Management
Puerto Rico
– -$233K -24,195 Closed
Simplex Trading
269
Simplex Trading
Illinois
– -$152K -15,318 Closed
GS
270
GTS Securities
New York
– -$100K -10,412 Closed
TLP
271
Tri Locum Partners
New York
– -$99.4K -10,326 Closed
HT
272
Headlands Technologies
Illinois
– -$64.9K -6,737 Closed
ACM
273
Aquatic Capital Management
Illinois
– -$19K -2,000 Closed
C
274
Covestor
United Kingdom
– -$8.97K -907 -98%
IA
275
IFP Advisors
Florida
– -$4.38K -455 Closed
8 9 10
11
12

IRWD Hedge Fund Activity: Q4 2023 in Review

251 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2023, worth a combined $1.91B — up 22% from $1.56B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new IRWD positions and 26 closed out — a net gain of 6 holders — while 87 added to existing stakes and 94 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $23.7M. The largest seller was Dimensional Fund Advisors, cutting an estimated $24.1M.

  • 251 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2023, up from 248 in Q3 2023.
  • Funds reported $1.91B of Ironwood Pharmaceuticals stock for Q4 2023, up 22% quarter-over-quarter.
  • 32 funds opened new Ironwood Pharmaceuticals positions in Q4 2023 and 26 closed out, a net change of +6 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2023 was Morgan Stanley, an estimated $23.7M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2023 was Dimensional Fund Advisors, an estimated $24.1M sold.

Based on aggregated 13F filings for Q4 2023.